Calviri Announces Completion of Groundbreaking Preventative Canine Cancer Vaccine Trial

PHOENIX, June 3, 2024 /PRNewswire/ — Calviri, Inc. announced the successful conclusion of the Vaccine Against Canine Cancer Study (VACCS) on May 4, 2024; a five-year clinical trial investigating a novel preventative cancer vaccine in dogs. This multi-center, double-blind, placebo-controlled study, the largest of its kind in veterinary oncology, represents a significant milestone in the fight against canine cancer.Continue reading

In Memoriam: Jack Kavanagh, co-founder of AzMN

John Thomas (Jack) Kavanagh, co-founder of the Arizona Myeloma Network (AzMN), passed away on Saturday, May 25, 2024 at the age of 87.  Diagnosed with Multiple Myeloma in 1991, Jack had a successful business career prior to retiring to Arizona in 2003 and creating AzMN with his wife Barbara in 2004.

Continue reading

Heard at BIO2024: Arizona is Amazing

The world biotechnology community converged in San Diego on June 3-6, 2024  for the BIO International Convention.  As of Monday morning over 18,500 people were registered to attend and over 60,000 partnering meetings had been scheduled. Arizona's health innovation community was well represented.  Joan Koerber-Walker, President & CEO of AZBio, spoke with investors, companies, family offices, industry leaders, and international organizations  to share what's happening in Arizona. In meeting after meeting and from conversation to conversation a theme emerged - what's happening in Arizona  is amazing.

Continue reading